Aurangzeb 2003.

Methods	Randomised, non‐blinded controlled clinical trial
Participants	Children between 3 to 72 months of age, admitted in the hospital with community‐acquired pneumonia
Interventions	The patients were randomly allotted to 1 of the 3 groups Group 1 was given amoxycillin 75 mg/kg/d IV in 3 divided doses, Group 2 was given cefuroxime 75 mg/kg/d IV in 3 divided doses and Group 3 was given clarithromycin 15 mg/kg/d IV divided into 2 divided doses
Outcomes	1. Improvement defined as slower respiratory rate (either back to normal for the age of the child), or more than 5 as compared to the previous day evaluation without retractions. The same defined as still breathing fast as before as or higher than that with no chest in drawing or danger signs 2. Worse was defined as development of severe pneumonia or very severe disease 3. Cure was defined as return of respiratory rate to age specific normal range
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	No information provided
Allocation concealment (selection bias)	Unclear risk	No information provided
Blinding of participants and personnel (performance bias) All outcomes	High risk	Open‐label study
Blinding of outcome assessment (detection bias) All outcomes	High risk	Open‐label study
Selective reporting (reporting bias)	Unclear risk	There are discrepancies in the number of patients in different study arms
Incomplete outcome data (attrition bias) All outcomes	Low risk	None
Other bias	Unclear risk	Source of funding not mentioned